NO960620D0 - Antipsykotisk fremgangsmåte - Google Patents
Antipsykotisk fremgangsmåteInfo
- Publication number
- NO960620D0 NO960620D0 NO960620A NO960620A NO960620D0 NO 960620 D0 NO960620 D0 NO 960620D0 NO 960620 A NO960620 A NO 960620A NO 960620 A NO960620 A NO 960620A NO 960620 D0 NO960620 D0 NO 960620D0
- Authority
- NO
- Norway
- Prior art keywords
- antipsychotic method
- antipsychotic
- schizophrenia
- susceptible
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Epoxy Resins (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10928593A | 1993-08-19 | 1993-08-19 | |
PCT/DK1994/000309 WO1995005379A1 (en) | 1993-08-19 | 1994-08-18 | Antipsychotic method |
Publications (3)
Publication Number | Publication Date |
---|---|
NO960620D0 true NO960620D0 (no) | 1996-02-16 |
NO960620L NO960620L (no) | 1996-04-18 |
NO310597B1 NO310597B1 (no) | 2001-07-30 |
Family
ID=22326851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19960620A NO310597B1 (no) | 1993-08-19 | 1996-02-16 | Anvendelse av oksadiazol- og tiadiazolforbindelser til fremstilling av farmasöytiske preparater for behandling avschizofreni eller schizofreniforme sykdommer |
Country Status (23)
Country | Link |
---|---|
US (3) | US5677313A (no) |
EP (1) | EP0714394B1 (no) |
JP (1) | JP3474575B2 (no) |
KR (1) | KR960703908A (no) |
CN (1) | CN1040979C (no) |
AT (1) | ATE202353T1 (no) |
CA (1) | CA2169838C (no) |
CZ (1) | CZ42796A3 (no) |
DE (1) | DE69427537T2 (no) |
DK (1) | DK0714394T3 (no) |
ES (1) | ES2160127T3 (no) |
FI (1) | FI960748A (no) |
GR (1) | GR3036587T3 (no) |
HU (1) | HU222116B1 (no) |
IL (1) | IL110727A (no) |
NO (1) | NO310597B1 (no) |
NZ (2) | NZ271313A (no) |
PT (1) | PT714394E (no) |
SG (1) | SG55072A1 (no) |
TW (1) | TW442285B (no) |
UA (1) | UA43347C2 (no) |
WO (1) | WO1995005379A1 (no) |
ZA (1) | ZA946321B (no) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ271313A (en) * | 1993-08-19 | 1999-09-29 | Novo Nordisk As | Pharmaceutical use of oxa-or thia-diazole-substd. azabicyclic ring compounds |
US5998404A (en) * | 1994-10-24 | 1999-12-07 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5672709A (en) * | 1994-10-24 | 1997-09-30 | Eli Lilly And Company | Heterocyclic compounds and their preparation and use |
US5605908A (en) * | 1994-10-24 | 1997-02-25 | Eli Lilly And Company | Heterocyclic compounds and their use |
US5488056A (en) * | 1994-10-31 | 1996-01-30 | Eli Lilly And Company | Method for treating anxiety |
US5574028A (en) * | 1994-10-31 | 1996-11-12 | Eli Lilly And Company | Method for treating anxiety |
US5726193A (en) * | 1994-10-31 | 1998-03-10 | Eli Lilly And Company | Method for treating anxiety |
PE17897A1 (es) * | 1995-02-17 | 1997-06-12 | Lilly Co Eli | Formulacion transdermica en parche del 3-(4-butiltio)-1,2,5-tiadiazol-3-il)-1-azabiciclo (2,2,2) octano |
US5763457A (en) * | 1995-11-13 | 1998-06-09 | Eli Lilly And Company | Method for treating anxiety |
US5852037A (en) * | 1995-11-13 | 1998-12-22 | Eli Lilly And Company | Method for treating anxiety |
WO1997020819A1 (en) * | 1995-12-06 | 1997-06-12 | Eli Lilly And Company | Composition for treating pain |
US20020022056A1 (en) | 1997-02-14 | 2002-02-21 | Burkhard Schlutermann | Oxacarbazepine film-coated tablets |
JP2001520653A (ja) * | 1997-04-11 | 2001-10-30 | エリ リリー アンド カンパニー | 精神分裂病の治療法 |
WO1998046227A1 (en) * | 1997-04-11 | 1998-10-22 | Eli Lilly And Company | Composition for treating pain |
US20040023951A1 (en) * | 2001-06-18 | 2004-02-05 | Bymaster Franklin Porter | Combination therapy for treatment of psychoses |
AU2008326360A1 (en) * | 2007-11-21 | 2009-05-28 | Abbott Laboratories | Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators |
WO2009140483A1 (en) | 2008-05-15 | 2009-11-19 | University Of Toledo | Muscarinic agonists as cognitive enhancers |
WO2012149524A1 (en) | 2011-04-29 | 2012-11-01 | The University Of Toledo | Muscarinic agonists as enhancers of working memory and cognitive flexibility |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0261763B1 (en) * | 1986-06-27 | 1994-02-09 | Beecham Group Plc | Novel bridged bicyclic N-heterocycles |
US4977176A (en) * | 1987-01-31 | 1990-12-11 | Sandoz Ltd. | Pilocarpine compounds which are used as pharmaceutical agents |
NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
DK198590D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
US5418240A (en) * | 1990-08-21 | 1995-05-23 | Novo Nordisk A/S | Heterocyclic compounds and their preparation and use |
NZ271313A (en) * | 1993-08-19 | 1999-09-29 | Novo Nordisk As | Pharmaceutical use of oxa-or thia-diazole-substd. azabicyclic ring compounds |
-
1994
- 1994-08-18 NZ NZ271313A patent/NZ271313A/en unknown
- 1994-08-18 DK DK94924710T patent/DK0714394T3/da active
- 1994-08-18 KR KR1019960700807A patent/KR960703908A/ko active IP Right Grant
- 1994-08-18 JP JP50669595A patent/JP3474575B2/ja not_active Expired - Fee Related
- 1994-08-18 CN CN94193738A patent/CN1040979C/zh not_active Expired - Fee Related
- 1994-08-18 HU HU9600363A patent/HU222116B1/hu not_active IP Right Cessation
- 1994-08-18 PT PT94924710T patent/PT714394E/pt unknown
- 1994-08-18 CZ CZ96427A patent/CZ42796A3/cs unknown
- 1994-08-18 ES ES94924710T patent/ES2160127T3/es not_active Expired - Lifetime
- 1994-08-18 NZ NZ336596A patent/NZ336596A/en unknown
- 1994-08-18 WO PCT/DK1994/000309 patent/WO1995005379A1/en not_active Application Discontinuation
- 1994-08-18 UA UA96020583A patent/UA43347C2/uk unknown
- 1994-08-18 SG SG1996004798A patent/SG55072A1/en unknown
- 1994-08-18 CA CA002169838A patent/CA2169838C/en not_active Expired - Fee Related
- 1994-08-18 EP EP94924710A patent/EP0714394B1/en not_active Expired - Lifetime
- 1994-08-18 DE DE69427537T patent/DE69427537T2/de not_active Expired - Fee Related
- 1994-08-18 AT AT94924710T patent/ATE202353T1/de not_active IP Right Cessation
- 1994-08-19 ZA ZA946321A patent/ZA946321B/xx unknown
- 1994-08-19 IL IL11072794A patent/IL110727A/en not_active IP Right Cessation
-
1995
- 1995-02-15 TW TW084101438A patent/TW442285B/zh not_active IP Right Cessation
- 1995-06-05 US US08/462,931 patent/US5677313A/en not_active Expired - Fee Related
- 1995-06-05 US US08/463,615 patent/US5968926A/en not_active Expired - Fee Related
- 1995-06-05 US US08/465,215 patent/US5679686A/en not_active Expired - Lifetime
-
1996
- 1996-02-16 NO NO19960620A patent/NO310597B1/no not_active IP Right Cessation
- 1996-02-19 FI FI960748A patent/FI960748A/fi unknown
-
2001
- 2001-09-11 GR GR20010401444T patent/GR3036587T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0714394T3 (da) | Antipsykotisk fremgangsmåde | |
DE69433394D1 (de) | Botulinustoxine zur Modulation cholinergisch-kontrollierter Sekretionen | |
FI20050461A (fi) | Antipsykoottinen käyttö | |
DE69421296D1 (de) | Schmelzbehandlung | |
NO944040D0 (no) | Induktivt ladeapparat | |
DE69401817D1 (de) | Verbesserungen zum herstellen von glasartigem silika | |
NO963785D0 (no) | Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser | |
NO953443D0 (no) | Fremgangsmåte for behandling av fast avfall | |
NO942906L (no) | Fremgangsmåte for oksydasjon av natriumsulfid | |
DE69324427D1 (de) | Neues endbehandlungsverfahren für hydroxyfunktionelle polythethern | |
ES2135477T3 (es) | Proceso de produccion de (s)-3-amino-1-pirrolidinas sustituidas. | |
NO941655D0 (no) | Fremgangsmåte for detektering av sulfider | |
NO990450D0 (no) | Behandling av sinnslidelser | |
DE69419598D1 (de) | Abstichverfahren für hochofen | |
FI933624A0 (fi) | Apparat foer pappers- och kartongmaskin samt dess anvaendning | |
TR200003083T2 (tr) | CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate. | |
ITTO930166A1 (it) | Procedimento per il trattamento di flussi reflui della produzione di n-fosfonometilglicina. | |
KR970004363U (ko) | 협잡물 처리용 원심분리기 | |
BR9304842A (pt) | Processo de produção de ferro-gusa | |
SE9303214D0 (sv) | Process I | |
FI931153A0 (fi) | Anordning foer uppvaermning av stenmaterial | |
FIU930197U0 (fi) | Apparat foer slipning av skridskor | |
KR950009954U (ko) | 브라운관 재생용 어닐링로 | |
KR960024336U (ko) | 유리제 난시용 안경렌즈 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |
Free format text: LAPSED IN FEBRUARY 2003 |